69 related articles for article (PubMed ID: 28492995)
1. Cervical cancer survivorship: long-term quality of life and social support.
Pfaendler KS; Wenzel L; Mechanic MB; Penner KR
Clin Ther; 2015 Jan; 37(1):39-48. PubMed ID: 25592090
[TBL] [Abstract][Full Text] [Related]
2. Quality of life in long-term cervical cancer survivors compared with healthy women and women with benign gynecological disorders.
Cea García J; Rodríguez Jiménez I; Márquez Maraver F; Ríos-Pena L; Carmen Rubio Rodríguez M
Eur J Obstet Gynecol Reprod Biol; 2024 Jun; 297():78-85. PubMed ID: 38583275
[TBL] [Abstract][Full Text] [Related]
3. Lower Body Lymphedema in Patients with Gynecologic Cancer.
Biglia N; Zanfagnin V; Daniele A; Robba E; Bounous VE
Anticancer Res; 2017 Aug; 37(8):4005-4015. PubMed ID: 28739682
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for late-onset lower limb lymphedema after gynecological cancer treatment: A multi-institutional retrospective study.
Yoshihara M; Shimono R; Tsuru S; Kitamura K; Sakuda H; Oguchi H; Hirota A
Eur J Surg Oncol; 2020 Jul; 46(7):1334-1338. PubMed ID: 32146054
[TBL] [Abstract][Full Text] [Related]
5. Feature Importance Analysis of a Deep Learning Model for Predicting Late Bladder Toxicity Occurrence in Uterine Cervical Cancer Patients.
Cheon W; Han M; Jeong S; Oh ES; Lee SU; Lee SB; Shin D; Lim YK; Jeong JH; Kim H; Kim JY
Cancers (Basel); 2023 Jul; 15(13):. PubMed ID: 37444573
[TBL] [Abstract][Full Text] [Related]
6. Quality of Life in Cervical Cancer Survivors Treated with Concurrent Chemoradiotherapy.
Stuopelytė R; Žukienė G; Breivienė R; Rudaitis V; Bartkevičienė D
Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109735
[No Abstract] [Full Text] [Related]
7. Sexual dysfunction among gynecologic cancer survivors in a population-based cohort study.
Chang CP; Wilson CM; Rowe K; Snyder J; Dodson M; Deshmukh V; Newman M; Fraser A; Smith K; Date A; Stanford JB; Gaffney D; Mooney K; Hashibe M
Support Care Cancer; 2022 Dec; 31(1):51. PubMed ID: 36526929
[TBL] [Abstract][Full Text] [Related]
8. Management Strategies for Sexuality Complaints after Gynecologic Cancer: A Systematic Review.
Pizetta LM; Reis ADC; Méxas MP; Guimarães VA; de Paula CL
Rev Bras Ginecol Obstet; 2022 Oct; 44(10):962-971. PubMed ID: 36174653
[TBL] [Abstract][Full Text] [Related]
9. Factors of sexual quality of life in gynaecological cancers: a systematic literature review.
Roussin M; Lowe J; Hamilton A; Martin L
Arch Gynecol Obstet; 2021 Sep; 304(3):791-805. PubMed ID: 33847794
[TBL] [Abstract][Full Text] [Related]
10. Body Image, Sexuality, and Sexual Functioning in Women With Gynecologic Cancer: An Integrative Review of the Literature and Implications for Research.
Wilson CM; McGuire DB; Rodgers BL; Elswick RK; Temkin SM
Cancer Nurs; 2021 Sep-Oct 01; 44(5):E252-E286. PubMed ID: 32332264
[TBL] [Abstract][Full Text] [Related]
11. Late side effects of 3T MRI-guided 3D high-dose rate brachytherapy of cervical cancer : Institutional experiences.
Vojtíšek R; Sukovská E; Baxa J; Budíková M; Kovářová P; Fínek J
Strahlenther Onkol; 2019 Nov; 195(11):972-981. PubMed ID: 31309266
[TBL] [Abstract][Full Text] [Related]
12. Frequency and risk factors for arm lymphedema after multimodal breast-conserving treatment of nodal positive breast Cancer - a long-term observation.
Rupp J; Hadamitzky C; Henkenberens C; Christiansen H; Steinmann D; Bruns F
Radiat Oncol; 2019 Mar; 14(1):39. PubMed ID: 30845971
[TBL] [Abstract][Full Text] [Related]
13. The value of pretreatment serum butyrylcholinesterase level as a novel prognostic biomarker in patients with cervical cancer treated with primary (chemo-)radiation therapy.
Poetsch N; Sturdza A; Aust S; Polterauer S; Grimm C; Schwameis R; Pötter R; Koelbl H; Reinthaller A; Seebacher V
Strahlenther Onkol; 2019 May; 195(5):430-440. PubMed ID: 30737542
[TBL] [Abstract][Full Text] [Related]
14. Age-corrected hearing loss after chemoradiation in cervical cancer patients.
Marnitz S; Schermeyer L; Dommerich S; Köhler C; Olze H; Budach V; Martus P
Strahlenther Onkol; 2018 Nov; 194(11):1039-1048. PubMed ID: 30120496
[TBL] [Abstract][Full Text] [Related]
15. Impact of cervical cancer on quality of life of women in Hubei, China.
Thapa N; Maharjan M; Xiong Y; Jiang D; Nguyen TP; Petrini MA; Cai H
Sci Rep; 2018 Aug; 8(1):11993. PubMed ID: 30097622
[TBL] [Abstract][Full Text] [Related]
16. Normal tissue damage: its importance, history and challenges for the future.
Williams JP; Newhauser W
Br J Radiol; 2019 Jan; 92(1093):20180048. PubMed ID: 29616836
[TBL] [Abstract][Full Text] [Related]
17. General health status of long-term cervical cancer survivors after radiotherapy.
Sung Uk L; Young Ae K; Young-Ho Y; Yeon-Joo K; Myong Cheol L; Sang-Yoon P; Sang-Soo S; Ji Eun P; Joo-Young K
Strahlenther Onkol; 2017 Jul; 193(7):543-551. PubMed ID: 28492995
[TBL] [Abstract][Full Text] [Related]
18. Salvage radiotherapy with or without concurrent chemotherapy for pelvic recurrence after hysterectomy alone for early-stage uterine cervical cancer.
Kim SW; Chun M; Ryu HS; Chang SJ; Kong TW; Lee EJ; Lee YH; Oh YT
Strahlenther Onkol; 2017 Jul; 193(7):534-542. PubMed ID: 28357468
[TBL] [Abstract][Full Text] [Related]
19. Health-Related Quality of Life in Locally Advanced Cervical Cancer Patients After Definitive Chemoradiation Therapy Including Image Guided Adaptive Brachytherapy: An Analysis From the EMBRACE Study.
Kirchheiner K; Pötter R; Tanderup K; Lindegaard JC; Haie-Meder C; Petrič P; Mahantshetty U; Jürgenliemk-Schulz IM; Rai B; Cooper R; Dörr W; Nout RA;
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1088-98. PubMed ID: 26876955
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
